Skip to main content
Premium Trial:

Request an Annual Quote

Affy Reports $85M in Preliminary Q4 Revenues

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix today reported $85 million in preliminary revenue for the fourth quarter — a 6 percent increase over $78.6 million in the fourth quarter of 2009.

The company said that its anticipated fourth-quarter 2010 revenue includes a $4.8 million milestone payment from an undisclosed diagnostic partner.

Affy said that it expects to report positive operating income and net income on a GAAP basis for the fourth quarter of 2010, but did not provide additional details.

The company also said that it has repurchased $53 million in 3.5 percent convertible notes. It repurchased more than $150 million of the notes in 2010 and now has about $95 million in outstanding convertible debt.

Affymetrix said it expects to have a year-end net cash balance of around $140 million.

The company plans to report its complete financial results for the fourth quarter and full year on Feb. 2.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.